Morgan Stanley (MS) concluded trading on Wednesday at a closing price of $122.20, with 5.08 million shares of worth about $620.47 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.25% during that period and on March 26, 2025 the price saw a loss of about -2.40%. Currently the company’s common shares owned by public are about 1.61B shares, out of which, 1.23B shares are available for trading.
Stock saw a price change of 1.96% in past 5 days and over the past one month there was a price change of -5.71%. Year-to-date (YTD), MS shares are showing a performance of -2.80% which increased to 32.90% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $85.01 but also hit the highest price of $142.03 during that period. The average intraday trading volume for Morgan Stanley shares is 6.95 million. The stock is currently trading 1.47% above its 20-day simple moving average (SMA20), while that difference is down -5.98% for SMA50 and it goes to 5.55% higher than SMA200.
Morgan Stanley (NYSE: MS) currently have 1.61B outstanding shares and institutions hold larger chunk of about 61.74% of that.
The stock has a current market capitalization of $197.09B and its 3Y-monthly beta is at 1.27. PE ratio of stock for trailing 12 months is 15.38, while it has posted earnings per share of $7.95 in the same period. Its PEG reads 1.55 while making debt-to-equity ratio of 3.64. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MS, volatility over the week remained 2.49% while standing at 3.31% over the month.
Stock’s fiscal year EPS is expected to rise by 9.43% while it is estimated to increase by 10.20% in next year. EPS is likely to grow at an annualized rate of 9.93% for next 5-years, compared to annual growth of 8.89% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Morgan Stanley (MS) stock as an Equal weight in their note to investors on November 15, 2024, suggesting a price target of $142 for the stock. Stock get an Underweight rating from Wells Fargo on August 02, 2024.
